MARY MENTZER: Open Payments
NPI 1962858258 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $91 |
| Amgen Inc. | 2 | $47 |
| Fresenius USA Marketing, Inc. | 2 | $43 |
| Calliditas Therapeutics US Inc. | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $23 |
| Apellis Pharmaceuticals, Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
Products named: IBSRELA, KRYSTEXXA, VELPHORO, TARPEYO, ULTOMIRIS, Empaveli, Vanrafia, FARXIGA.
Industry payments across NC — which companies pay providers there.
